Autoantibodies to heterogeneous nuclear ribonucleoproteins

Autoimmunity

Volumn 38, Issue 1, 2005, Pages 25-32

  Caporali, Roberto ^a   Bugatti, Serena ^a   Bruschi, Eleonora ^a   Cavagna, Lorenzo ^a   Montecucco, Carlomaurizio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Autoantibodies; Heterogeneous nuclear ribonucleoproteins; Mixed connective tissue disease; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; EPITOPE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; NUCLEAR PROTEIN; RNA;

ARTICLE; AUTOIMMUNE DISEASE; COMPLEX FORMATION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUKARYOTIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MIXED CONNECTIVE TISSUE DISEASE; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TARGETING; RHEUMATIC DISEASE; RNA SPLICING; RNA TRANSLATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP C; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HISTORY, 20TH CENTURY; HUMANS; IMMUNOGLOBULIN ISOTYPES; RHEUMATIC DISEASES;

EID: 17144407977     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930400022590     Document Type: Article

References (72)

1. von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995;24:323-358.
2. Griesmacher A, Peichl P. Autoantibodies associated with rheumatic diseases. Clin Chem Lab Med 2001;39:189-208.
3. Van Venrooij W, Pruijin GJM. Ribonucleoprotein complexes as autoantigens. Curr Opin Immunol 1995;7:819-824.
4. Dreyfuss G, Piňol-Roma S, Burd CG. HnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 1993;62:289-321.
5. Swanson MS. Functions of nuclear pre-mRNA/mRNA binding proteins. In: Lamond AI, editor. Pre-mRNA Processing. Berlin/Heidelberg: Landes Co Springer Verlag; 1995. p 17-33.
6. Biamonti G, Ghigna C, Caporali R, Montecucco C. Heterogeneous nuclear ribonucleoproteins (hn-RNPs): An emerging family of autoantigens in rheumatic diseases. Clin Exp Rheumatol 1998;16:317-326.
7. Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: one protein multiple processes. Bioessays 2004;26:629-638.
8. Michelotti EF, Michelotti GA, Aronsohn AI, Levens D. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol 1996;16:2350-2360.
9. LaBranche H, Dupuis S, Ben-David Y, Bani MR, Wellinger RJ, Chabot B. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet 1998;19:199-202.
10. Mayeda A, Krainer AR. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 1992;68:365-375.
11. Michael WM, Eder PS, Dreyfuss G. The K nuclear shuttling domain: A novel signal for nuclear import and nuclear export in the hnRNP K protein. EMBO J 1997;16:3587-3598.
12. Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M, Hentze MW. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 1997;89:597-606.
13. Kiledjian M, DeMaria CT, Brewer G, Novick K. Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of die alpha-globin mRNA stability complex. Mol Cell Biol 1997;17:4870-4876.
14. Hassfeld W, Steiner G, Hartmuth K, Kolarz G, Scherak O, Graninger W, et al. Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum 1989;32:1515-1520.
15. Steiner G, Hartmuth K, Skriner K, Maurer-Fogy I, Sinski A, Thalmann E, et al. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Investig 1992;90:1061-1066.
16. Fritzler MJ, Ali R, Tan EM. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix. J Immunol 1984;132:1216-1222.
17. Zouali M, Eyquem A. Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases. J Clin Immunol 1984;4:209-219.
18. Habets WJ, de Rooij DJ, Salden MH, Verhagen AP, van Eekelen CA, van de Putte LB, et al. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol 1983;54:265-276.
19. Gelpi C, Rodriguez-Sanchez JL, Hardin JA. Purification of hnRNP from HeLa cells with a monoclonal antibody and its application in ELISA: detection of autoantibodies. Clin Exp Immunol 1988;71:281-288.
20. Astaldi Ricotti GC, Pazzaglia M, Martelli AM, Cerino A. Autoantibodies to purified nuclear proteins related to DNA metabolism during ageing and in SLE patients. Immunology 1987;61:375-381.
21. Siomi H, Dreyfuss G. A nuclear localization domain in the hnRNP A1 protein. J Cell Biol 1995;129:551-560.
22. Jensen L, Kuff EL, Wilson SH, Steinberg AD, Klinman DM. Antibodies from patients and mice with autoimmune diseases react with recombinant hnRNP core protein A1. J Autoimmun 1988;1:73-83.
23. Astaldi Ricotti GC, Bestagno M, Cerino A, Negri C, Caporali R, Cobianchi F, et al. Antibodies to hnRNP core protein A1 in connective tissue diseases. J Cell Biochem 1989;40:43-47.
24. Montecucco C, Caporali R, Negri C, de Gennaro F, Cerino A, Bestagno M, et al. Antibodies from patients with rheumatoid arthritis and systemic lupus erythematosus recognize different epitopes of a single heterogeneous nuclear RNP core protein. Possible role of cross-reacting antikeratin antibodies. Arthritis Rheum 1990;33:180-186.
25. Steiner G, Skriner K, Smolen JS. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: Novel tools for the diagnosis of rheumatic diseases. Int Arch Allergy Immunol 1996;111:314-319.
26. Montecucco C, Caporali R, Cobianchi F, Negri C, Astaldi-Ricotti GC. Antibodies to hn-RNP protein A1 in systemic lupus erythematosus: Clinical association with Raynaud's phenomenon and esophageal dysmotility. Clin Exp Rheumatol 1992;10:223-227.
27. Hassfeld W, Steiner G, Studnicka-Benke A, Skriner K, Graninger W, Fischer I, et al. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum 1995;38:777-785.
28. Montecucco C, Caporali R, Cobianchi F, Biamonti G. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis. Arthritis Rheum 1996;39:1669-1676.
29. Jones DA, Yawalkar N, Suh KY, Sadat S, Rich B, Kupper TS. Identification of autoantigens in psoriatic plaques using expression cloning. J Investig Dermatol 2004;123:93-100.
30. Kamma H, Horiguchi H, Wan L, Matsui M, Fujiwara M, Fujimoto M, et al. Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms. Exp Cell Res 1999;246:399-411.
31. Weighardt F, Biamonti G, Riva S. The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. Bioessays 1996;18:747-756.
32. Krecic AM, Swanson MS. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 1999;11:363-371.
33. Mayeda A, Munroe SH, Caceres JF, Krainer AR. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J 1994;13:5483-5495.
34. Dangli A, Guialis A, Vretou E, Sekeris CE. Autoantibodies to the core proteins of hnRNPs. FEBS Lett 1988;231:118-124.
35. Skriner K, Steiner G, Sommergruber WH, Sinski A, Smolen JS. Anti-RA33 autoantibodies may recognize epitopes in the N-terminal region of hnRNP-A2 (RA33). Clin Exp Rheumatol 1994;12(Suppl. 11):S79-S82.
36. Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, et al. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. J Clin Investig 1997;100:127-135.
37. Cartegni L, Maconi M, Morandi E, Cobianchi F, Riva S, Biamonti G. hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins. J Mol Biol 1996;259:337-348.
38. Dumortier H, Monneaux F, Jahn-Schmid B, Briand JP, Skriner K, Cohen PL, et al. B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus mice. J Immunol 2000;165:2297-2305.
39. Monneaux F, Dumortier H, Steiner G, Briand JP, Muller S. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(1pr) and (NZB × NZW)F(1) lupus mice. Int Immunol 2001;13:1155-1163.
40. Schett G, Hayer S, Tohidast-Akrad M, Schmid BJ, Lang S, Turk B, et al. Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice. Arthritis Rheum 2001;44:2888-2898.
41. Steiner G, Shovman O, Skriner K, Gilburd B, Langevitz P, Miholits M, et al. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice. Clin Exp Rheumatol 2002;20:517-524.
42. Fritsch R, Eselbock D, Skriner K, Jahn-Schmid B, Scheinecker C, Bohle B, et al. Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. J Immunol 2002;169:1068-1076.
43. Hayer S, Tohidast-Akrad M, Schett G, Gabalawy HEI, Smolen J, Steiner G. Overexpression of the autoantigen hnRNP-A2 (RA33), the tumour suppressor p53 and activated MAP-kinase p38 in inflamed synovial tissue. Arthritis Res 2002;4(Suppl. 1):38.
44. Greidinger EL, Gazitt T, Jaimes KF, Hoffman RW. Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production. Arthritis Rheum 2004;50:2216-2222.
45. Sun KH, Tang SJ, Wang YS, Lin WJ, You RI. Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2. Rheumatology 2003;42:154-161.
46. Merrill BM, Barnett SF, LeStourgeon WM, Williams KR. Primary structure differences between proteins C1 and C2 of HeLa 40S nuclear ribonucleoprotein particles. Nucleic Acids Res 1989;17:8441-8449.
47. Burd CG, Swanson MS, Gorlach M, Dreyfuss G. Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: A diversity of RNA binding proteins is generated by small peptide inserts. Proc Natl Acad Sci USA 1989;86:9788-9792.
48. Soltaninassab SR, McAfee JG, Shahied-Milam L, LeStourgeon WM. Oligonucleotide binding specificities of the hnRNP C protein tetramer. Nucleic Acids Res 1998;26:3410-3417.
49. Beyer AL, Christensen ME, Walker BW, LeStourgeon WM. Identification and characterization of the packaging proteins of core 40S hnRNP particles. Cell 1977;11:127-138.
50. Soulard M, Barque JP, Della Valle V, Hernandez-Verdun D, Masson C, Danon F, et al. A novel 43-kDa glycoprotein is detected in the nucleus of mammalian cells by autoantibodies from dogs with autoimmune disorders. Exp Cell Res 1991;193:59-71.
51. Stanek D, Vencovsky J, Kafkova J, Raska I. Heterogenous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis. Arthritis Rheum 1997;40:2172-2177.
52. Heegaard NH, Larsen MR, Muncrief T, Wiik A, Roepstorff P. Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods. Arthritis Res 2000;2:407-414.
53. Soulard M, Della Valle V, Siomi MC, Pinol-Roma S, Codogno P, Bauvy C. hnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res 1993;21:4210-4217.
54. Soulard M, Della Valle V, Larsen CJ. Autoimmune antibodies to hnRNPG protein in dogs with systemic lupus erythematosus: epitope mapping of the antigen. J Autoimmun 2002;18:221-229.
55. Soulard M, Della Valle V, Monod G, Prelaud P, Lacroix JC, Larsen CJ. The I protein of the heterogeneous nuclear ribonucleoprotein complex is a novel dog nuclear autoantigen. J Autoimmun 1996;9:599-608.
56. Weighardt F, Biamonti G, Riva S. The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. Bioessays 1996;18:747-756.
57. Ghetti A, Pinol-Roma S, Michael WM, Morandi C, Dreyfuss G. hnRNP I the polypyrimidine tract-binding protein: Distinct nuclear localization and association with hnRNAs. Nucleic Acids Res 1992;20:3671-3678.
58. Valai, A, Belisova, A, Hayer, S, Hoefler, E, Steiner, G. (2004) The RNA binding domains of hnRNP K contain major autoepitopes targeted by patients with SLE and other autoimmune diseases. ICI/FOCIS Abstracts. Abstract number 1148.
59. Hassfeld W, Chan EK, Mathison DA, Portman D, Dreyfuss G, Steiner G, et al. Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: Immunological relationship with hnRNP P. Nucleic Acids Res 1998;26:439-445.
60. Schett G, Monneaux F, Hoefler E, Fritsch R, Tohidast-Akrad M, Smolen J, et al. Autoantibodies to hnRNP-A2 in SLE: Identification of disease-specific linear epitopes and correlation with disease activity and clinical features. Arthritis Res Ther 2003;5(Suppl. 1):25.
61. Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS. Autoantibody to the nuclear antigen RA33: A marker for early rheumatoid arthritis. Br J Rheumatol 1993;32:199-203.
62. Meyer O, Tauxe F, Fabregas D, Gabay C, Goycochea M, Haim T, et al. Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies. Clin Exp Rheumatol 1993;11:473-478.
63. Cordonnier C, Meyer O, Palazzo E, de Bandt M, Elias A, Nicaise P, et al. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol 1996;35:620-624.
64. Aho K, Steiner G, Kurki P, Paimela L, Leirisalo-Repo M, Palosuo T, et al. Anti-RA 33 as a marker antibody of rheumatoid arthritis in a Finnish population. Clin Exp Rheumatol 1993;11:645-647.
65. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236-243.
66. Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J, et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: A multiparameter prospective study. Arthritis Rheum 2001;44:1736-1743.
67. Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Arthritis Rheum 1998;41:1938-1945.
68. Gabay C, Prieur AM, Meyer O. Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis. Ann Rheum Dis 1993;52:785-789.
69. Isenberg DA, Steiner G, Smolen JS. Clinical utility and serological connections of anti-RA33 antibodies in systemic lupus erythematosus. J Rheumatol 1994;21:1260-1263.
70. Richter Cohen M, Steiner G, Smolen JS, Isenberg DA. Erosive arthritis in systemic lupus erythematosus: Analysis of a distinct clinical and serological subset. Br J Rheumatol 1998;37:421-424.
71. Montecucco C. Antibodies to RNP and their clinical significance. Br J Rheumatol 1990;29:322-324.
72. Smolen JS, Steiner G. Mixed connective tissue disease: To be or not to be? Arthritis Rheum 1998;41:768-777.